top of page
Search

7 Novel Drugs Approved by the FDA in Q1 2025

  • Orbit Dot
  • 14 minutes ago
  • 1 min read

As we gear up for the second quarter, let’s take a quick look through the 7 novel drugs approved by the FDA in Q1 2025!


Oncology

  • DATROWAY - A game-changing therapy for breast cancer, specifically for unresectable or metastatic HR+ and HER2- types. Designed for patients who have already undergone prior therapies.

  • GOMEKLI - Making history as the first FDA-approved treatment for NF1.

  • ROMVIMZA - A new contender in the fight against TGCT.


Hematology

  • GRAFAPEX - Set to revolutionize the prep regimen for allogeneic hematopoietic stem cell transplantation; it's a crucial step for those battling AML and myelodysplastic syndrome.

  • QFITLIA - Targeting hemophilia A and B, this innovative treatment seeks to reduce the frequency of bleeding episodes.


Urology

  • BLUJEPA - A new solution for uncomplicated UTIs.


Pain Medicine

  • JOURNAVX - Addressing moderate to severe acute pain to enhance pain management strategies.


Every new drug is a step forward in transforming patient care and opening up new possibilities. 🚀✨ Stay tuned for more updates! 🔍



 
 
 

Comments

bottom of page